Medical Clinic of Houston, LLP (MCH) is a well-established independent, multi-specialty physician group practice with a founding year of 1968. Their mission is to deliver outstanding medical care in a compassionate and service-oriented setting, making use of the latest medical technology. MCH's primary focus is on adult Internal Medicine, offering specialized services in Cardiology, Endocrinology, Gastroenterology, Rheumatology, and Medical Oncology/Hematology. They ensure same-day access to comprehensive in-house ancillary and diagnostic support services such as non-invasive cardiology studies, chemotherapy and infusion services, laboratory, diagnostic imaging, nutrition, diabetes education, and executive and corporate health and travel services. With a United States headquarters, MCH plays a vital role in the healthcare industry, delivering essential medical services and leveraging advanced technology. Although specific information regarding their recent investment and investors is currently unavailable, the company's extensive history and established presence in the industry position it as a potential candidate for investment opportunities within the healthcare sector. With advancements in medical technology and an increasing demand for quality healthcare services, MCH presents a compelling proposition for potential investors aiming to tap into the continuously growing healthcare market.
There is no investment information
No recent news or press coverage available for Medical Clinic of Houston, LLP.